Skip to content
Clinical Trials – home

Centrum Medyczne Ogrodowa Sp. z o.o

Verified siteinfo

Poland ul. Batalionów Chłopskich 2b, 99-400 Lowicz, Poland

  • 1 trial recruiting
  • Atrial fibrillation · Cardiac failure · Obesity
  • Adult patients

About Specializations

Centrum Medyczne Ogrodowa Sp. z o.o in Lowicz, Poland specialises in clinical trials of conditions such as Atrial fibrillation, Cardiac failure, Obesity, and other specialisations. This site conducts important research.

Main research areas of the site

Cardiovascular Diseases Research

At Centrum Medyczne Ogrodowa Sp. z o.o in Łowicz, the clinical trial portfolio is centered on cardiovascular diseases, with a strong focus on improving care for people living with atrial fibrillation and related heart conditions. The studies are designed to evaluate new treatment options and compare them with established therapies, aiming to better prevent serious complications such as stroke and systemic embolism.

  • Prevention of stroke and systemic embolism in people with atrial fibrillation
  • Testing and comparing new anticoagulant therapies for better protection against cardioembolic events
  • Assessing treatment benefit and safety in patients at risk of thromboembolic complications

The site is also involved in research for HFpEF and HFmrEF combined with obesity, where the goal is to determine whether new therapy can help reduce heart failure-related events and improve outcomes for patients with complex cardiometabolic disease.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
ul. Batalionów Chłopskich 2b99-400 LowiczPoland
Recruiting now
1 trial
Conditions studied
3
Partner status
Verified site

More sites in LowiczPoland

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

2 clinical trials

Cardiac failure+1

Recruiting

Study of Zenagamtide (NNC0487-0111) versus placebo in patients with heart failure with preserved or mildly reduced ejection fraction and obesity

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:POLYPEPTIDE CONSISTING OF A GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST AND AN AMYLIN RECEPTOR AGONIST, CONNECTED BY A LINKER WITH 4 GLYCINE RESIDUES, AND CONNECTED TO A C18 FATTY ACID SIDE CHAIN
  • Sponsor:Novo Nordisk A/S

Atrial fibrillation

Not recruiting

Study on Milvexian and Apixaban for Preventing Stroke in Patients with Atrial Fibrillation

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Andexanet Alfa
  • Sponsor:Janssen Cilag International
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.